Wednesday May 5, 9:06 am Eastern Time
Company Press Release
Scottsdale Scientific Receives Approval From Bindley Western Industries to
Service Their Customer Base
Bindley Western Industries (NYSE: BDY) Services Over 12,000 Pharmacies and Operates 15
Distribution Centers Across the U.S.
SCOTTSDALE, Ariz.--(BW HealthWire)--May 5, 1999-- Scottsdale Scientific, Inc. (Symbol: STDS), through its wholly owned subsidiary NutriCology, Inc.,
announced today that it has received approval from Bindley Western Industries, Inc. (NYSE: BDY - news) to service their customers on a drop ship basis.
This will enable Scottsdale Scientific to solicit orders from over 12,000 pharmacies serviced by Bindley Western (NYSE: BDY - news), whose headquarters are in
Indianapolis, Indiana. ''This is the first step in what promises to become a major market for the Company,'' states Marianne Sum, President and CEO of Scottsdale
Scientific. Ms. Sum further states, ''Our penetration into the pharmacy market has just begun. Conservative estimates suggest sales through the Bindley Western
(Symbol: BDY) customer base should exceed $1.5Million by year end. This would represent a 300% increase in sales in the pharmacy market.''
Clinton Abbott has been appointed to head up the new division. Clinton brings to the Company 20 years of wholesale pharmaceutical experience. His role will be to
develop this emerging market. The marketing efforts will be backed by an extensive marketing plan directed towards the pharmacist. Pharmacists are among the
most trusted professionals in the U.S. today. Through educating the pharmacist and their staff to the benefits of nutritional supplementation, Scottsdale Scientific feels
they can also build the same trust with the pharmacist as the Company enjoys among physicians. This will lead to the pharmacist recommending the products of
Scottsdale Scientific over those of its competitors.
In 1997, over-the-counter sales in the pharmacy market topped $25Billion. While overall sales exceed $112Billion. As the public's awareness increases in the
direction of proper nutritional supplementation, the pharmacy market is shifting towards alternative healthcare. This category of healthcare has been included in the
plan-o-grams of most pharmacy wholesalers. This change from the health food store to the pharmacy marks the acceptance of alternative healthcare to the
mainstream and will spark significant growth in the nutraceutical industry as a whole. Scottsdale Scientific sees the difference between its products and those
currently offered in the pharmacy market as an issue of quality and purity. As a leader among the providers of alternative healthcare for the past 20 years, Scottsdale
Scientific feels its name recognition will also play a large role in the success of the pharmacy division.
Scottsdale Scientific, Inc., through its wholly owned subsidiary, NutriCology, Inc. is an innovative leader in nutraceutical research and product formulation. Since
1979, the Company is noted for quality, hypoallergenic nutritional supplements and supplies products to approximately 6,000 physicians and health care practitioners
world-wide. Allergy Research Group was the first in the U.S. to introduce numerous specialty products including melatonin, a neurohormone, germanium
sesquioxide (a trace mineral), AntiOx(tm), a broad-spectrum antioxidant, Buffered Vitamin C and the Total Nutrient Concept. (Includes all in one, proprietary
formulas, Total Immune(tm), Total Nerve(tm) and Total Heart(tm)) For additional information, visit our web site at www.nutricology.com
Disclaimer: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other
than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements
filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on
behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking
statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Contact:
Scottsdale Scientific
Wendy Miller-Appleyard
(888) 607-5399 or (602) 948-7444
|
